02:42 PM EDT, 07/11/2025 (MT Newswires) -- Milestone Pharmaceuticals ( MIST ) said Friday that it has priced an underwritten public offering to raise about $52.5 million.

The company said it is offering 31.5 million shares with accompanying Series A and Series B warrants to purchase the same number of shares at $1.50 per share and warrants.

It is also offering some 3.5 million pre-funded warrants, attached with accompanying Series A and B warrants, at $1.499 each.

Milestone said it plans to use the net proceeds to help fund the clinical development and commercial launch of etripamil, as well as for working capital and other general corporate purposes.

The offering will likely close July 14.

The shares were down about 38% in recent trading.

Price: 1.59, Change: -0.98, Percent Change: -38.09